Potential of Multidimensional, Large-scale Biodatabases to Elucidate Coagulation and Platelet Pathways as an Approach...

Area of Science:

• Cardiovascular research
• Thrombosis and hemostasis
• Biomedical data science

Background:

• Thrombotic diseases are a leading cause of global morbidity and mortality.
• Large-scale biodatabases have significantly advanced the understanding of thrombosis and hemostasis.
• Integrating multi-omics and clinical data offers a comprehensive approach to disease research.

Purpose of the Study:

• To review the utility of biodatabases in analyzing the interplay of coagulation and cellular elements in thrombotic disease.
• To explore the application of biodatabases in venous thromboembolism research.
• To discuss the links between venous and arterial thrombotic diseases and the role of platelet biomarkers.

Main Methods:

• Review of current literature on biodatabase applications in thrombosis and hemostasis.
• Analysis of high-throughput technologies for large-scale clinical investigations.
• Integration of clinical, environmental, genomic, and molecular data.

Main Results:

• Biodatabases facilitate comprehensive research by integrating diverse data types.
• Multi-pathway analysis using integrated data provides a more robust model of disease pathogenesis than single markers.
• Examples of biodatabase use in venous thromboembolism and connections to arterial diseases are presented.

Conclusions:

• Large-scale biodatabase analyses are crucial for understanding the complex pathogenesis of thrombotic diseases.
• The integration of multiple data levels enhances the predictive power for clinical outcomes.
• Platelet biomarkers and their role in thrombosis and hemostasis are increasingly important in research.